Institute Of Biomedical Stock Performance
| MRES Stock | USD 0.01 0 13.97% |
The company retains a Market Volatility (i.e., Beta) of 0.51, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Institute's returns are expected to increase less than the market. However, during the bear market, the loss of holding Institute is expected to be smaller as well. At this point, Institute of Biomedical has a negative expected return of -0.12%. Please make sure to check out Institute's potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Institute of Biomedical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Institute of Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
Institute |
Institute Relative Risk vs. Return Landscape
If you would invest 1.70 in Institute of Biomedical on December 24, 2024 and sell it today you would lose (0.53) from holding Institute of Biomedical or give up 31.18% of portfolio value over 90 days. Institute of Biomedical is currently does not generate positive expected returns and assumes 10.5151% risk (volatility on return distribution) over the 90 days horizon. In different words, 93% of pink sheets are less volatile than Institute, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Institute Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Institute's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Institute of Biomedical, and traders can use it to determine the average amount a Institute's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0115
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MRES |
Estimated Market Risk
| 10.52 actual daily | 93 93% of assets are less volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Institute is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Institute by adding Institute to a well-diversified portfolio.
Institute Fundamentals Growth
Institute Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Institute, and Institute fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Institute Pink Sheet performance.
| Current Valuation | 198.84 K | |||
| Shares Outstanding | 66.28 M | |||
| Price To Book | 0.69 X | |||
| Revenue | 1.41 M | |||
| Cash Flow From Operations | 2.06 M | |||
| Total Asset | 5.28 M | |||
| Retained Earnings | (55.58 M) | |||
| Current Asset | 2.56 M | |||
| Current Liabilities | 3.8 M | |||
About Institute Performance
Assessing Institute's fundamental ratios provides investors with valuable insights into Institute's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Institute is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Institute of Biomedical Research Corp. was founded in 2010 and is based in Podgorica, Montenegro with a representative office in Montreal, Canada. Institute is traded on OTC Exchange in the United States.Things to note about Institute of Biomedical performance evaluation
Checking the ongoing alerts about Institute for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Institute of Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Institute generated a negative expected return over the last 90 days | |
| Institute has high historical volatility and very poor performance | |
| Institute has some characteristics of a very speculative penny stock |
- Analyzing Institute's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Institute's stock is overvalued or undervalued compared to its peers.
- Examining Institute's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Institute's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Institute's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Institute's pink sheet. These opinions can provide insight into Institute's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Institute Pink Sheet Analysis
When running Institute's price analysis, check to measure Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Institute is operating at the current time. Most of Institute's value examination focuses on studying past and present price action to predict the probability of Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Institute's price. Additionally, you may evaluate how the addition of Institute to your portfolios can decrease your overall portfolio volatility.